199 related articles for article (PubMed ID: 33657423)
1. Mechanisms of the antiangiogenic effects of aspirin in cancer.
Xie S; Wang Y; Huang Y; Yang B
Eur J Pharmacol; 2021 May; 898():173989. PubMed ID: 33657423
[TBL] [Abstract][Full Text] [Related]
2. Complex roles of the old drug aspirin in cancer chemoprevention and therapy.
Hua H; Zhang H; Kong Q; Wang J; Jiang Y
Med Res Rev; 2019 Jan; 39(1):114-145. PubMed ID: 29855050
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase.
Dai X; Yan J; Fu X; Pan Q; Sun D; Xu Y; Wang J; Nie L; Tong L; Shen A; Zheng M; Huang M; Tan M; Liu H; Huang X; Ding J; Geng M
Clin Cancer Res; 2017 Oct; 23(20):6267-6278. PubMed ID: 28710312
[No Abstract] [Full Text] [Related]
4. The great escape; the hallmarks of resistance to antiangiogenic therapy.
van Beijnum JR; Nowak-Sliwinska P; Huijbers EJ; Thijssen VL; Griffioen AW
Pharmacol Rev; 2015; 67(2):441-61. PubMed ID: 25769965
[TBL] [Abstract][Full Text] [Related]
5. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.
Marech I; Leporini C; Ammendola M; Porcelli M; Gadaleta CD; Russo E; De Sarro G; Ranieri G
Cancer Lett; 2016 Sep; 380(1):216-26. PubMed ID: 26238184
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic therapy for cancer: current and emerging concepts.
Jain RK
Oncology (Williston Park); 2005 Apr; 19(4 Suppl 3):7-16. PubMed ID: 15934498
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic therapy: a novel approach to overcome tumor hypoxia.
Peng F; Chen M
Chin J Cancer; 2010 Aug; 29(8):715-20. PubMed ID: 20663317
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic agents in cancer therapy.
Lenz HJ
Oncology (Williston Park); 2005 Apr; 19(4 Suppl 3):17-25. PubMed ID: 15934499
[TBL] [Abstract][Full Text] [Related]
9. The Past and Future of Angiogenesis as a Target for Cancer Therapy and Prevention.
Albini A; Noonan DM; Corradino P; Magnoni F; Corso G
Cancer Prev Res (Phila); 2024 Jul; 17(7):289-303. PubMed ID: 38714356
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic Effect of Flavonoids and Chalcones: An Update.
Mirossay L; Varinská L; Mojžiš J
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271940
[TBL] [Abstract][Full Text] [Related]
11. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
[TBL] [Abstract][Full Text] [Related]
12. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenesis: the fifth cancer treatment modality?
Camp-Sorrell D
Oncol Nurs Forum; 2003; 30(6):934-44. PubMed ID: 14603351
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in antiangiogenic therapy.
Dredge K; Dalgleish AG; Marriott JB
Expert Opin Biol Ther; 2002 Dec; 2(8):953-66. PubMed ID: 12517273
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and current antiangiogenic strategies for the treatment of cancer.
Oklu R; Walker TG; Wicky S; Hesketh R
J Vasc Interv Radiol; 2010 Dec; 21(12):1791-805; quiz 1806. PubMed ID: 20980167
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.
Pircher A; Jöhrer K; Kocher F; Steiner N; Graziadei I; Heidegger I; Pichler R; Leonhartsberger N; Kremser C; Kern J; Untergasser G; Gunsilius E; Hilbe W
Oncotarget; 2016 Apr; 7(15):20109-23. PubMed ID: 26956051
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic potential of novel antiangiogenic therapies.
Scappaticci FA
Expert Opin Investig Drugs; 2003 Jun; 12(6):923-32. PubMed ID: 12783597
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive effects of aspirin at a glance.
Usman MW; Luo F; Cheng H; Zhao JJ; Liu P
Biochim Biophys Acta; 2015 Apr; 1855(2):254-63. PubMed ID: 25842298
[TBL] [Abstract][Full Text] [Related]
19. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
Wachsberger P; Burd R; Dicker AP
Clin Cancer Res; 2003 Jun; 9(6):1957-71. PubMed ID: 12796357
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of tumor neovascularization.
Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]